VANCOUVER, BC, CANADA (December 10, 2019) – Mota Ventures Corp. (CSE: MOTA) (the “Company”) is pleased to announce that Clifford Starke has been appointed as a director of the Company, effective immediately.

Mr. Starke is the Chairman of Hampstead Private Capital, a Bermuda based merchant bank focused on financing and advising small to mid-market, fast growth companies.  Over the course of the last five years, Mr. Starke has focused on the cannabis sector and has acted as a founder, early stage shareholder, financier, advisor and director to multiple cannabis companies in sub-sectors ranging from genetics, cultivation, distribution, and e-commerce that have cumulatively generated over $3 billion dollars of market capitalization.  Currently, Mr. Starke is the Chief Executive Officer of Franchise Cannabis Corp., a leading European focused pharmaceutical cannabis company with distribution networks across eighteen countries and the current market leader in Germany.  Mr. Starke holds a Bachelor of Arts Degree from Queen’s University.

“As we enter the next wave in the cannabis sector, I believe significant shareholder value will be created in the international markets,” said Mr. Starke.  “I feel confident in the MOTA team as they have previously demonstrated operational and execution ability in the sector and I expect them to be very active in finding accretive international opportunities.  I am pleased to join the Board and will advise, direct, and provide relationships where needed to ensure MOTA realizes its vision and achieves success.”

Mr. Starke fills the vacancy created by Patrick Morris, who has resigned from the board to focus on other ventures.  The board extends its gratitude to Mr. Morris for his service to the Company over the years.

About Mota Ventures Corp.

Mota Ventures is seeking to become a large-scale vertically integrated low-cost producer and exporter of the highest quality CBD products worldwide. The 2.5 hectare site located in Colombia has optimal year round growing conditions and access to all necessary infrastructure. The site is located approximately 2 hours outside of Bogota 20 minutes away from the free trade zone and 30 minutes away from the international airport.  Phase one will consist of a state of the art 60,000 square foot greenhouse with the capacity to produce more than 14,000,000 grams per year along with build out of the Company’s extraction facilities.  The Company will focus on CBD extraction to produce pure raw CBD, with the goal to make value added CBD products and create its own brand to be sold internationally.


Joel Shacker

Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, Chief Executive Officer at +1.236.521.2177 or by email at or

This news release may contain certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws.  When or if used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target, “plan”, “forecast”, “may”, “schedule” and similar words or expressions identify forward-looking statements or information.  These forward-looking statements or information may relate to the anticipated business activities of the Company and the reliability of third party information and other factors or information.  Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties.  For the purposes of such statements, the Company has assumed the regulatory regime in place in Colombia will continue to permit its subsidiary, Ihuana, to cultivate non-psychoactive cannabis and produce CBD.  Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. Such factors include changes to the regulatory regime in Colombian with respect to the cultivation of non-psychoactive cannabis and production of CBD. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.